After separation and recombination of chains derived from antibody molecules, a combination of specific heavy (H) and light (L) chains usually provides the most avid binding sites, although isolated specific H and L chains may have some affinity for the antigen. The assembly of H and L chains of different specificities gives molecules with reduced antibody activity.'-7 Experiments on myeloma cells indicate that H and L chains are made on different classes of polyribosomes,8' 9 but the mechanisms which bring them together are not clear. If, as is generally believed, one plasma cell synthesizes antibodies of but a single specificity, there is no possibility of assembling chains of different specificities. However, the situation might be different in a cell-free system in which the protein-synthesizing apparatus of cells of different specificities are no longer kept apart. In the absence of a special mechanism for assembling chains of like specificity, the resulting antibody activity might be minimal or absent. In this case, a cell-free system would be of no use for exploring the roles of such factors as messenger RNA, transfer RNA, or ribosomal surface in the acquisition of antibody specificity. Evaluation of these factors, modifiable only under cell-free conditions, requires a system in which synthesis of protein with definite and easily measured antibody activity occurs.
After separation and recombination of chains derived from antibody molecules, a combination of specific heavy (H) and light (L) chains usually provides the most avid binding sites, although isolated specific H and L chains may have some affinity for the antigen. The assembly of H and L chains of different specificities gives molecules with reduced antibody activity.'-7 Experiments on myeloma cells indicate that H and L chains are made on different classes of polyribosomes,8' 9 but the mechanisms which bring them together are not clear. If, as is generally believed, one plasma cell synthesizes antibodies of but a single specificity, there is no possibility of assembling chains of different specificities. However, the situation might be different in a cell-free system in which the protein-synthesizing apparatus of cells of different specificities are no longer kept apart. In the absence of a special mechanism for assembling chains of like specificity, the resulting antibody activity might be minimal or absent. In this case, a cell-free system would be of no use for exploring the roles of such factors as messenger RNA, transfer RNA, or ribosomal surface in the acquisition of antibody specificity. Evaluation of these factors, modifiable only under cell-free conditions, requires a system in which synthesis of protein with definite and easily measured antibody activity occurs.
The present study, using a system previously described,10 shows that H and L chains can be completed in cell-free conditions, and combined to form molecules with significant antibody activity, located within the microsomal vesicles. This may indicate the cell-free assembly of H and L chains of the same specificity, made possible because the microsomal vesicles, whose structure is well preserved in the cell-free system used, are the site of assembly of immunoglobulin chains in the intact cell.
Materials and Methods.-Rabbit, rat, and bovine gamma globulin (BGG), and bovine serum albumin (BSA) were obtained from Pentex, Inc., and 2,4-dinitrophenyl-lysine (DNP-lysine) and streptomycin sulfate from Mann Research Laboratories. DNP-BGG (50 hapten groups/mole of protein), DNP-BSA (10 groups/mole), and p-toluenesulfonyl-e-aminocaproic acid (tosyl-EACA) were prepared." Bromoacetylcellulose (BAC) was prepared, coupled to DNP-BSA or BSA, and washed according to Robbins et al.;'2 the coupled adsorbent was kept in 9 vol of phosphate-buffered saline (0.15 M NaCl-0.01 M phosphate, pH 7.0) (PBS). H3-leucine (5 c/mM) and a C"4-amino acid mixture were purchased from New England Nuclear Corp. Rats were injected in each footpad with 2 X 1() killed H. pertussis (Eli Lilly and Co.), alone or mixed with 50 mug DNP-BGG.13 After 1 week the rats were killed and the lymph nodes excised.
Cell-free incubation: Preparation of microsomes from lymph nodes and conditions of cell-free incubation were as described previously,'0 except that the concentration of sucrose in the incubation medium was 0.25 or 0.44 M. One mg protein/ml of lymph node microsomes and 2 mg/ml of liver pH 5 fraction were incubated in the presence of either 10 M&c/ml of H3-leucine or a mixture of C'4-amino acids (the latter only for the autoradiographic studies) in a total volume of 20 ml.
After 30 min, 10 or 20 ml of ice-cold incubation medium were added to the cell-free system, which was kept in ice for 5 min and centrifuged for 60 min at 105,000 gay. Aliquots of the supernatant were kept for determination of protein radioactivity.'0 The microsomal pellet was resuspended in 10 ml of medium A with 0.25 M sucrose and 0.6% deoxycholate, and centrifuged for 90-120 min at 105,000 g. Aliquots of this latter supernatant (hereafter termed "microsomal extract") and of the ribosomal pellet were used for the determination of protein radioactivity. 10 Intact cell incubation: Lymph nodes were minced in small fragments in Eagle's minimal essential medium devoid of leucine (Grand Island Biol. Co.), incubated for 60 min at 370C in the presence of H'-leucine (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) sc/ml of medium), rinsed twice in chilled Hanks' solution, and then homogenized in medium A containing 0.88 M sucrose. A microsomal fraction was obtained under the same conditions as for the cell-free system,10 and similarly treated with deoxycholate to obtain a microsomal extract. Column chromatography: The microsomal extracts were dialyzed for 24 hr at 40C against 8 liters of phosphate buffer, 0.05 M, pH 8.0, and passed through a 10 X 1.2-cm column of 0-(diethylaminoethyl) cellulose (DEAE-cellulose) (DE 52, Whatman) equilibrated with the same buffer. For antibody assay, the first 20 ml of eluate were concentrated fivefold by ultrafiltration.
Gel filtration: The protein in the first 20 ml from the DEAE-cellulose column was lyophilized and then passed, sometimes along with carrier rat or rabbit ganuna globulin, after either extensive or no reduction, through a 67 X 2.5-cm column of Sephadex G-200 equilibrated with 4 M guanidine-HCl.'4 All protein was alkylated with iodoacetamide-in the case of unreduced protein to inhibit disulfide exchange.15 After dialysis against distilled water, carrier BSA (2 mg) was added to each fraction, and the protein was precipitated in HC104, 0.5 M, at 00C, heated 20 min at 900C to hydrolyze any residual transfer RNA which could carry H-leucine, and processed for determination of its radioactivity.'0 Antibody assay: Test tubes containing either (1) 1 ml of the radioactive fraction to be assayed, 1 ml of BAC suspension, and 1 ml of PBS, or (2) 1 ml of radioactive fraction and 1.5 mg of DNP-BGG in 0.5 ml of PBS were rotated for 30 min at 250C. In assay (2), 1.5 ml of PBS containing Results.-It is known that proteins synthesized on membrane-bound ribosomes pass into the content of the microsomal vesicles after completion of the polypeptide chains."6 Therefore, at the end of the cell-free incubation the microsomal vesicles were reisolated by centrifugation, treated with deoxycholate to dissolve the membranes, and centrifuged to remove the liberated ribosomes, leaving the completed protein molecules in a soluble form and any incomplete polypeptide chains attached to the ribosomal pellet. The soluble fraction obtained after deoxycholate treatment contained 8-16 per cent of the total radioactivity incorporated into protein, representing only those polypeptide chains which were completed and released into the microsomal vesicles under cell-free conditions. This fraction, which also contains the unlabeled content of the vesicles and the solubilized membranes, will be referred to as "microsomal extract."
Detection of immunoglobulin molecules synthesized in the cell-free system: Labeled immunoglobulins were demonstrated in the microsomal extracts obtained after cell-free incubation with C14-amino acids by autoradiography of the immunoelectrophoretic pattern formed with carrier rat serum ( Fig. 1 have different elution patterns from DEAE-cellulose; the bulk of the microsomal proteins adheres to the column and immunoglobulins are not retained (Fig. 2) . Under the same conditions, a portion of the radioactivity from cell-free microsomal extracts (15-30%) elutes in the "immunoglobulin region" (Fig. 3 ). This first fraction (termed "DEAE-fraction") was used for structural studies and the antibody assay.
This fraction or its products were filtered through Sephadex G-200 equilibrated with 4 M guanidine HCl with the following results: (1) When the radioactive DEAE-fraction, mixed with nonradioactive carrier immunoglobulin, is reduced and alkylated before gel filtration, two radioactive peaks, containing about 70 per cent of the total radioactivity, coincide with the peaks of H and L chains of the cold carrier (Fig. 4) ; there is more radioactivity in the L than in the H peak. (2) When the DEAE-fraction is not reduced before gel filtration, about 50 per cent of the radioactivity appears with the 7S oy globulin peak or earlier; about 30 per cent is found in a peak corresponding to L chains; and the rest is distributed through the H-chain region (Fig. 5) . (3) When the radioactive molecules of the unreduced DEAE-fraction which are larger than H chains are pooled after gel filtration (radioactivity to the left of the vertical dashed line in Fig. 5) , concentrated, extensively reduced and alkylated, and again filtered through the Sephadex column, peaks of radioactivity corresponding to H and L, chains are evident (Fig. 6 ). For comparative purposes, the same chromatographic separations and gel filtration analyses were also performed on microsomal extracts obtained from intact lymph node cells incubated for 60 minutes in the presence of H3-leucine. The results differed in the following respects: (1) When the DEAE-fraction is reduced and alkylated, the radioactivity in the H and L peaks is also about 70 per cent of the total, but is greater in the H than in the LJ peak. (2) When the DEAE-fraction is not reduced, 90-100 per cent of the radioactivity appears with the oy globulin peak or earlier; in some cases radioactivity (always less than 10%6) was also observed in free L chains. The presence of some labeled material larger than 7S oy globulin molecules, both before and after reduction, was observed with DEAE-fractions obtained from cell-free and whole-cell systems. These large molecules (or aggregates) were not investigated further.
Antibody activity of the immunoglobulin chains synthesized in the cell-free system: Lymph nodes were obtained from animals immunized with either DNP-BGG and H. pertussis or H. pertussis alone, and microsomal extracts were prepared from intact cells previously incubated for 60 procedures identical to those used for the cell-free system. These microsomal extracts were used to find a suitable antibody assay which could be rigorously controlled. Precipitation methods were found to be unreliable, e.g., spurious anti-DNP activity in extracts from animals immunized against H. pertussis alone. Binding to insoluble immunoadsorbents followed by release of the fixed antibody by excess hapten was an improvement, but gave completely satisfactory results only when DEAE-fractions, and not total microsomal extracts, were used, perhaps because of the elimination of the lipoproteins of the solubilized membranes, a potential source of nonspecific binding. Two types of immunoadsorbents were used: DNP-BGG (the immunizing antigen) precipitated by streptomycin, and BAC coupled to DNP-BSA. After incubation of the immunoadsorbent with the DEAE-fraction, the necessity and effectiveness of the different washing steps described in Methods were determined by measuring the radioactivity released by various washing media. Elution of radioactivity from the extensively washed immunoadsorbent by DNP-lysine did not necessarily indicate specific binding since DNP-lysine always released some radioactivity, even when the material tested did not contain antibodies to DNP. The system thus requires its own "internal control." This was provided by comparing the radioactivity released The assay used allowed detection of antibody activity with great reliability in very small amounts of radioactive material. When DEAE-fractions from rats immunized with H. pertussis alone were tested, the ratio of DNP-released to tosylreleased counts usually varied between 0.8 and 1.2, and was never higher than 1.5. When fractions from DNP-immunized animals were assayed, this ratio varied between 8 and 20 or more, depending upon the amount of radioactive antibodies. The fraction of the radioactivity in DNP antibody was taken to be the percentage of counts eluted by DNP-lysine minus that released by tosyl-EACA, or by either hapten from BSA-BAC. The assay was performed on DEAE-fractions from five different cell-free incubations. In three instances the assay was run simultaneously with DEAE-fractions containing the same amount of radioactivity, but obtained from intact cells after incorporation in vitro. In all the cell-free experiments anti-DNP activity was found and represented 4-8 per cent of the total radioactivity exposed to the adsorbent. With the cellular systems, anti-DNP activity accounted for 14-17 per cent of the radioactivity when the animals had been immunized with DNP-BGG, and was absent when immunization was with H. pertussis alone. Results of two experiments are presented in Table 1 .
Discussion.-The results show that synthesis of immunoglobulin molecules with antibody activity can be achieved in a cell-free environment. Both H and L chains are completed, but L chains are synthesized or released in greater amounts. Free H chains were not found. Similar observations have been made with intact cells of a mouse myeloma and of rabbit lymph nodes. 18.19 The absence or rarity of free H Recently, Gusdon et al.,20 using a co-precipitation assay, have reported the cellfree synthesis of antibody in a system derived from rabbit lymph nodes.2' In the present work an immunoadsorbent was used to detect antibody, and the dependability of the assay was ascertained by evaluating the specificity of the results as influenced by: (1) the material assayed, by using DEAE-fractions from animals immunized with H. pertussis alone; (2) the immunoadsorbent, by using adsorbents coupled to BSA without DNP groups; (3) the eluting solution, by using the tosyl hapten, whose benzene ring lacks nitro groups. Most of the anti- to bind antigenic determinants,' 7 the affinity is so low that they can hardly be considered responsible for a significant part of the radioactivity specifically bound. About one half of the labeled protein assayed for antibody activity in the cell-free extract was smaller in size than -y G and presumably had poor, if any, binding affinity for DNP. In contrast, almost all protein synthesized in the cellular system used for the assay was of 'y G size or larger. Therefore, if one considers only radioactivity in whole oy globulin molecules, the percentage of radioactive antibodies to DNP is probably similar for the cell-free system and intact cells. This would indicate that in the cell-free system, in spite of the mixing of microsomes synthesizing H and L chains of different specificities, chains of similar specificity have no more difficulty joining together to form an anti-DNP combining site than in intact cells. This probably occurs because the combination of H and L chains takes place in the cavity of microsomal vesicles. In cell-free systems each microsomal vesicle with its bound ribosomes must synthesize and contain only H and L chains of one specificity, corresponding to the specificity of the plasma cell from which it originates, so that the assembly of H and L chains into immunoglobulin molecules would avoid competition between chains of different specificities. It is known that polypeptide chains synthesized by membrane-bound ribosomes grow in the direction of the microsomal cavity, where they are released upon completion. 16 In the case of plasma cells, a small pool of free L chains, which are synthesized at a faster rate than H chains, would always be present in the microsomal vesicles, where they would combine with H chains as soon as these are completed, or, if the combination occurs before their completion,8 as soon as a sufficient portion of the N-terminal end of the H chain has reached the microsomal cavitv. The concept that microsomal vesicles are the site of assembly of immunoglobulin chains is compatible with electron microscopic and cell-fractionation studies. 22 23 In the present study, protein molecules with antibody activity have been synthesized using activating enzymes and transfer RNA's obtained from liver. Our results, however, do not eliminate the possibility that specific activating enzymes and transfer RNA's play some "modulating" role in the translation of messenger RNA in antibody-producing cells. 24' 25 It is possible that synthesis of the N-terminal, variable portions of most of the chains which were completed occurred prior to establishing cell-free conditions and that only C-terminal invariant halves were synthesized under cell-free conditions. However, we have shown that antibody synthesis can at least be completed in a cell-free environment. With further refinements, if necessary, to allow synthesis of polypeptide chains from N-terminal to C-terminal, the influence of such factors as messenger RNA, transfer RNA, and ribosomal surface on the control of the amino acid sequence of the variable regions should be amenable to direct study.
Summary.-The cell-free synthesis (or completion) of y G immunoglobulin by purified microsomal vesicles from rat lymph node cells is reported. Newly synthesized protein, present within the microsomal vesicles, was characterized by autoradiography of immunoelectrophoretic patterns and by gel filtration, with or with-out prior reduction. Radioactive amino acids were incorporated into the H and L chains of whole molecules, and were also found in free L chains. Cell-free synthesis of antibodies to the dinitrophenyl hapten was shown by means of immunoadsorbents.
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